Giselle Sholler

Giselle Sholler: Exciting to see Norgine moving forward with seeking approval for DFMO internationally

Giselle Sholler,

“Exciting to see Norgine moving forward with seeking approval for Difluoromethylornithine (DFMO) internationally!! Great news for children with neuroblastoma worldwide!”

Additional information.
Source: Giselle Sholler/LinkedIn

 

cancer DFMO Difluoromethylornithine Drug Approval Giselle Sholler neuroblastoma Norgine OncoDaily Oncology Pediatric Hematology pediatric oncology Penn State Health